Randomization to Extend Stroke Intravenous ThromboLysis In Evolving Non-Large Vessel Occlusion With TNK (RESILIENT

NCT05199662 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

466

Enrollment

OTHER

Sponsor class

Conditions

Ischemic Stroke, Acute

Interventions

DRUG: Intravenous tenecteplase
DRUG: Placebo

Sponsor

Hospital Moinhos de Vento

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]